ANDROGENETIC ALOPECIA (AGA)

This study tests if combining PRP (platelet-rich plasma) with Botox injections works better than PRP alone for treating androgenetic alopecia (male/female pattern baldness). About 76 adults aged 18-60 with mild to moderate hair loss will receive monthly scalp injections for three…

This study tests a new drug called OLX72021 for male pattern baldness. It involves 158 men aged 18-59 with mild to moderate hair loss. Participants receive multiple injections into the scalp to see if the treatment safely increases hair count compared to a placebo.

This study tests if a cream made from a friendly bacteria, Lactobacillus reuteri, can safely help people with common hair loss (androgenetic alopecia). About 388 adults will use either the probiotic cream, a placebo, or standard minoxidil for 12 months. The goal is to see if the …

This study tests whether a new peptide-based hair serum works better than the standard treatment, minoxidil, for people with pattern hair loss. About 80 adults with mild to moderate hair loss will use either the peptide serum or minoxidil for 24 weeks. Researchers will measure ch…

This study tests an experimental oral drug called VDPHL01 for women with androgenetic alopecia, a common genetic form of hair loss. About 552 women aged 18-65 with mild to moderate hair loss will receive either the drug or a placebo for 13 months. The goal is to see if the drug i…

This early-stage trial tests a new medication called ABS-201 to see if it is safe and tolerable for treating hair loss in men and women. It starts with healthy volunteers and then includes people with androgenetic alopecia (common pattern baldness). Participants receive either AB…